Clinical Trials Logo

Filter by:
NCT ID: NCT00284635 Completed - Clinical trials for Unicompartmental Knee Replacement

Fast-Track vs Conventional for UKA

Start date: n/a
Phase: Phase 4
Study type: Interventional

The purpose of this study is to see if it is possible to discharge patient undergoing a UKA 1 day postoperatively

NCT ID: NCT00284999 Completed - Dry Eye Syndromes Clinical Trials

Soothe Versus Refresh

Start date: n/a
Phase: Phase 4
Study type: Interventional

To determine the ocular efficacy and safety of Soothe and Refresh Tears.

NCT ID: NCT00285961 Completed - Wounds and Injuries Clinical Trials

Evaluation of Cork Splint Materials Instead of Plaster Splint for Children

Start date: n/a
Phase: N/A
Study type: Interventional

This is an evaluation of the functionality and added value of cork splint materials instead of a plaster splint for children (3-11 years old).

NCT ID: NCT00286247 Completed - Clinical trials for Locally Advanced Breast Cancer (LABC)

Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer

Start date: n/a
Phase: Phase 2
Study type: Interventional

A maximum of 60 subjects will be enrolled in the trial. It is a non-randomized, open label, single center study. All subjects undergo INGN 201 injection and IV chemotherapy: doxorubicin and docetaxel. This is done on the first 2 days of a 3-week cycle. After completion of 4 to 6 cycles, the subject either proceeds to surgery if the tumors respond to therapy, or goes off study if there is no tumor response.

NCT ID: NCT00286364 Completed - Infertility Clinical Trials

Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

Start date: n/a
Phase: Phase 4
Study type: Interventional

We want to investigate if early follicular phase downregulation and androgen priming, by use of GnRH antagonist, aromatase inhibitor and hCG before COH in a short protocol, shows signs of improvement compared to standard short antagonist protocol

NCT ID: NCT00286884 Completed - Healthy Clinical Trials

Heart Rate Variability in White Coat Hypertension and Essential Hypertension

Start date: n/a
Phase: N/A
Study type: Observational

The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.

NCT ID: NCT00286975 Completed - Clinical trials for Leadership Skills and Knowledge in Postgraduate Trainees

Growing Future Physician Leaders: A Randomized Trial of an Educational Intervention in Postgraduate Trainees

Start date: n/a
Phase: Phase 4
Study type: Interventional

Study objective: The objective of this trial was to determine the effectiveness of a Leadership Development Program (LDP) aimed at 1) establishing basic management knowledge and 2) promoting reflection of leadership skills. Study design: Randomized, controlled, single-blind trial. Study participants: Senior postgraduate medical and surgical trainees at an urban university health care centre. Methods: Eligible participants were randomized to either the LDP(intervention group) or to regular postgraduate training (control group). For ethical reasons, all participants assigned to the control group were offered the LDP at the end of the trial. The 1º outcome measure used was a knowledge-based written exam. The sample size was estimated on finding a 20% difference in mean test scores between groups. Participants' reflective capacity and higher order leadership role skills were tested through a personal learning project (PLP, 2º outcome measure).

NCT ID: NCT00290173 Completed - Pregnancy Clinical Trials

Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor

Start date: n/a
Phase: N/A
Study type: Interventional

This is a trial comparing the efficacy of oral ritodrine in the form of sustained release capsules for the maintenance of uterine quiescence after successfully treated episode of threatened preterm labor.

NCT ID: NCT00290381 Completed - Allergic Rhinitis Clinical Trials

The Effects of OC000459 on Nasal Mediators

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Interventional

This is the first proof of concept study for OC000459 and is undertaken to assess the effects of the compound on the development of inflammatory cytokines in a model (nasal allergen challenge model) that is validated and clinically safe and easy to conduct. OC000459 will be compared with placebo in the study. The study will be a randomised, double blind, placebo controlled, crossover evaluation of the effect of OC000459 on cytokine secretion induced by nasal allergen challenge. Male subjects with a known history of allergic rhinitis and screening positive to allergen will be included. After dosing with OC000459 or placebo, nasal allergen challenge will be performed and measurements made in the nasal fluids. Nasal symptom scores will also be recorded. Safety parameters will be monitored throughout.

NCT ID: NCT00290914 Completed - Clinical trials for Major Depressive Disorder

Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose is to evaluate the safety and usefulness of the investigational drug, vilazodone in depression.